Patricia F Hughes Troost
FDA Investigator Report
Total Inspections: 16
Total 483s Issued: 11
Total Warning Letters Issued: 0
Inspection Details
Longest Inspection: 5 days
Shortest Inspection: 1 days
Average Length of Inspection: 2.1 days
Discover the bigger picture. This is just the tip of the iceberg.
Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.
Schedule a DemoRecent Inspections
Date | Company | City | Country | FEI Number | 483 |
---|
2022-07-15 | Revance Therapeutics Inc | Newark | United States | 3007772056 | |
2016-05-06 | Lonza Biologics, Inc. | Portsmouth | United States | 3001451441 | |
2016-03-24 | ImClone Systems, LLC | Branchburg | United States | 3002889358 | |
2015-10-09 | Lotte Biologics USA, LLC | East Syracuse | United States | 1317757 | |
2014-06-13 | United Therapeutics Corporation | Silver Spring | United States | 3003368324 | |
2013-02-07 | Lotte Biologics USA, LLC | East Syracuse | United States | 1317757 | |
2013-02-07 | Bristol-Myers Squibb Co., Inc. | East Syracuse | United States | 1317461 | |
2012-04-13 | Bristol-Myers Squibb Company | Devens | United States | 3008455069 | |
2011-06-10 | AbbVie Bioresearch Center | Worcester | United States | 3003684386 | |
2009-09-29 | Genzyme Flanders BVBA | Geel | Belgium | 3003623839 | |
Co-Inspectors
Active Locations
- United States
- Netherlands
- France
- Belgium
- Switzerland
- Japan
- Israel
Year-wise Inspection Count
- 2008: 1 inspections
- 2009: 6 inspections
- 2011: 1 inspections
- 2012: 1 inspections
- 2013: 2 inspections
- 2014: 1 inspections
- 2015: 1 inspections
- 2016: 2 inspections
- 2022: 1 inspections